R-2A Activity · President's Budget PB2027

Smart Red Blood Cells (Smart-RBC)

FY2027 Request
$21.2M
▲ 431% vs FY2026
HitchAI read

This activity requests $21.2M in FY2027, 11% of project WP-02, up 431% on FY2026. The R-2A exhibit describes it across FY2026–FY2027, including what the FY2027 money is planned to buy.

FY2027 Request
$21.2M
▲ 431% vs FY2026
FY2026 Enacted
$4.0M
In law
Planned work

What the FY2027 request buys

Verbatim from the R-2A exhibit for project WP-02 of PE 0602024E. This is the budget justification's own description of work that has not happened yet — the one thing no other level of the budget carries.

FY2027 planned work

- Continue studies on editing cells to produce, position, and retain novel proteins in mature RBCs. - Continue computer simulation of gene editing impact on RBC metabolism and virtually optimize protein position/retention on mature RBCs. - Initiate experiments to produce, position, and retain novel proteins in mature RBCs. - Identify any changes in RBC function due to the genetic modifications when compared to unmodified cells. - Initiate simulation experiments to optimize protein position/retention on a mature RBC. - Assess the type and character of circuits possible in RBCs based on gene editing experiments and protein expression.

FY2026 to FY2027 change

The FY 2027 increase reflects the expansion of studies on editing cells to produce, position, and retain novel proteins within and on the surface of RBCs.

Before the request year

FY2026: the year under way

Prior-year accomplishments and current-year plans from the same exhibit. Context for the FY2027 plan, not a series — an activity partitions its project exactly in the request year, but can under-cover it in earlier years.

FY2026 plans — current year

- Initiate studies on editing cells to produce, position, and retain novel proteins in mature red blood cells (RBCs). - Run a computer simulation of the gene editing impact on RBC metabolism.

Money

Three years, and no five-year plan

An R-2A activity publishes the prior year, the current year and the budget year. The FYDP outyears exist at project and program-element level and are deliberately absent here rather than inferred. Estimate types are colored and never summed into one figure.

04.0FY26ENACTED21.2FY27REQUEST
Enacted Request
Fiscal YearEstimate TypeAmount ($M)
FY2026Enacted4.0
FY2027Request21.2

This activity is 11% of project WP-02's FY2027 request and 5.8% of PE 0602024E's. In the request year the activities under a project sum to it exactly; in the current year they under-cover it in about 9% of cases, so an activity's delta can legitimately exceed its parent's and the two must not be compared row to row.

Where this sits

14 activities in project WP-02

Every R-2A line of this project, largest FY2027 request first. Linked where the activity has enough of its own narrative to carry a page; the rest are shown in full on the project page.

Biomedical Technology Studies and Concepts$57.2M ▲ 453%Generative Optogenetics (GO)$28.0M ▲ 80%
Smart Red Blood Cells (Smart-RBC) — this activity$21.2M ▲ 431%
Protean$15.7M ▲ 143%BioElectronics to Sense and Treat (BEST)$14.2M ▼ 15%Medics Autonomously Stopping Hemorrhage (MASH)$14.0M ▲ 52%Novel Delivery Technology for Medical Countermeasures$12.1M ▼ 36%
Alert WARfighter Enablement (AWARE)$6.1M ▼ 50%
Reengineering Enabling Sleep Transitions in Operationally Restrictive Environments (RESTORE)$5.7M ▼ 12%
Controlled Genome Protection$5.4M ▼ 26%
Red Blood Cell Factory (RBC-Factory)$5.3M ▼ 47%
GOLDen hour extended EVACuation (GOLDEVAC)$4.9M ▼ 73%
Rapid Battlefield Triage▼ 100%
Next-Generation Combat Casualty Care▼ 100%
Source
FY2027 Office of the Secretary of Defense RDT&E Budget Justification · Exhibit R-2A · PE 0602024E, project WP-02 (President's Budget PB2027). Congressional marks are recorded on the program element, never on an activity.
Machine access
Markdown twin /programs/0602024E/WP-02/a10.md · MCP mcp.hitchintel.combudget_get_activity